CHELSEA COUNSEL CO - IMMUNOCELLULAR THERAPEUTICS ownership

Quarter-by-quarter ownership
CHELSEA COUNSEL CO ownership history of IMMUNOCELLULAR THERAPEUTICS
ValueSharesWeighting
Q3 2016$3,000
-50.0%
26,0000.0%0.00%
-33.3%
Q2 2016$6,000
-25.0%
26,000
-7.1%
0.00%0.0%
Q1 2016$8,000
-20.0%
28,0000.0%0.00%0.0%
Q4 2015$10,000
-16.7%
28,0000.0%0.00%0.0%
Q3 2015$12,000
-7.7%
28,0000.0%0.00%0.0%
Q2 2015$13,000
-7.1%
28,0000.0%0.00%0.0%
Q1 2015$14,000
-30.0%
28,0000.0%0.00%
-25.0%
Q4 2014$20,000
-20.0%
28,0000.0%0.00%
-20.0%
Q3 2014$25,000
-19.4%
28,0000.0%0.01%
-16.7%
Q2 2014$31,000
-8.8%
28,0000.0%0.01%
-14.3%
Q1 2014$34,000
+30.8%
28,0000.0%0.01%
+16.7%
Q4 2013$26,000
-63.9%
28,0000.0%0.01%
-60.0%
Q3 2013$72,000
+33.3%
28,0000.0%0.02%
+7.1%
Q2 2013$54,00028,0000.01%
Other shareholders

There were no reported owners of IMMUNOCELLULAR THERAPEUTICS in Q3 2023.

NameSharesValueWeighting ↓
View complete list of IMMUNOCELLULAR THERAPEUTICS shareholders